Blood Cells Count Derived Inflammation Indexes as Predictors of Early Treatment Response to Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis

Derived inflammatory indexes from routine hematological parameters might be useful for predicting early-response vs. late/non-response to dupilumab, the first biological agent approved for moderate-to-severe atopic dermatitis (AD). We tested this hypothesis by retrospectively investigating the assoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Zinellu, Angelo, Sucato, Federica, Piras, Viviana, Addis, Gian Mario, Biondi, Gabriele, Montesu, Maria Antonia, Mangoni, Arduino A., Carru, Ciriaco, Pirina, Pietro, Paliogiannis, Panagiotis, Fois, Alessandro G., Satta, Rosanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056555/
https://www.ncbi.nlm.nih.gov/pubmed/36983107
http://dx.doi.org/10.3390/jcm12062104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056555/
https://www.ncbi.nlm.nih.gov/pubmed/36983107
http://dx.doi.org/10.3390/jcm12062104

Ejemplares similares